A CFRI-led team has reported the first clinical trial of an automated anesthesia drug delivery system for children, a major step towards more personalized anesthesia.

As students are heading into mid-terms, doctors and parents alike are concerned about children’s and adolescents’ consumption of caffeinated energy drinks. Dr. Ran Goldman, emergency room physician, paediatrician, and researcher with CFRI’s Innovations in Acute Care & Technology group, addresses these concerns in his most recent column in Canadian Family Physician, the peer-reviewed publication of the College of Family Physicians in Canada.

Development of a vaccine against Epstein-Barr virus (EBV) has taken a step forward with the Canadian discovery of how EBV infection evades detection by the immune system. 

A new study has shone a spotlight on the peacekeeping mechanisms in our intestines.

One size chart doesn’t fit all when it comes to evaluating birth weight and health outcomes of newborns.

Immigrant and refugee kids face many of challenges when they arrive in Canada. As a health professional, you're there to help them. To help you, our partners at the Canadian Paediatric Society have launched a www.kidsnewtocanada.ca, an online guide for health professionals working with immigrant and refugee children, youth and families.

Since the Vaccine Evaluation Centre (VEC) was founded as the first of its kind in Canada in 1988, the centre’s investigators have completed over 225 research studies with findings that have contributed towards developing new vaccines, improving vaccine safety, and refining public immunization programs.

The calls are coming with greater frequency, and greater urgency, from parents of children who have suffered a concussion, or might have suffered a concussion. They want clear, authoritative guidance, or a second opinion.

Two doses of Merck & Co.'s human papillomavirus vaccine may be just as effective in younger girls as the recommended three doses given to older teens and women to help protect them against the virus that causes cervical cancer, a Canadian study found.

Three doses of the human papillomavirus (HPV) vaccine are needed in order for the vaccine to be effective, health officials say, but many people who start the vaccination series don't finish it.

Dr. Michael O'Shaughnessy, a member of the CFRI Interim Leadership team, received the Queen Elizabeth II Diamond Jubilee Medal in January 2013. The medal honours significant contributions and achievements by Canadians to their fellow citizens, their communities and to Canada.

On February 26, 2013, Dr. Daniel Metzger and Dr. Bruce Verchere received the Queen Elizabeth II Diamond Jubilee Medal for their outstanding research and dedication to improving the lives of Canadians living with diabetes.

On December 30, 2012, Dr. David Scheifele was named an Officer of the Order of Canada for his contributions to improving health care through the prevention of infectious disease. The Order of Canada is one of the nation’s highest civilian honours and is awarded to recognize a lifetime of achievement and contribution to society.

Preterm infants who grow more slowly as they approached what would have been their due dates also have slower development in an area of the brain called the cerebral cortex, report Canadian researchers in a new study published today in Science Translational Medicine.

Canadian researchers are seeking 8666 teenage girls across the country for a new national study opening this month that will determine whether two or three doses of the vaccine Gardasil provide similar protection against human papillomavirus (HPV).

Risk can be useful training for children, recent scientific articles assert. In a report in the International Journal of Environmental Research and Public Health, CFRI researcher and UBC Psychologist Dr. Mariana Brussoni and colleagues suggest risky play ultimately keeps children safer by allowing them to learn how to take and manage risk.

A project aimed at finding and treating women at risk of succumbing to pre-eclampsia – the often-fatal onset of high blood pressure during pregnancy – will receive an additional $17 million from the Bill & Melinda Gates Foundation.

Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway’s activity also decreases inflammation. The finding offers a potential new drug target for treating CF lung disease, which is a major cause of illness and death for people with CF.

CFRI researcher Dr. Dina Panagiotopoulos is interviewed by The Globe and Mail for comment on a U.S. study that found that puberty among boys is starting six months to two years earlier than previously documented.

Dr. Peter von Dadelszen, a Clinician Scientist at CFRI and a world authority on diagnosing and treating pre-eclampsia, has received the 2012 Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR).